BIM
CVS icon

Bridgecreek Investment Management’s CVS Health CVS Stock Holding History

Bridgecreek Investment Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$5.23M Sell
66,225
-14,150
-18% -$1.01M 1.01% 29
2023
Q3 		$5.61M Buy
80,375
+50
+0.1% +$3.54K 1.15% 25
2023
Q2 		$5.55M Buy
80,325
+3,475
+5% +$247K 1.06% 28
2023
Q1 		$5.71M Buy
76,850
+225
+0.3% +$18.9K 1.18% 27
2022
Q4 		$7.14M Sell
76,625
-75
-0.1% -$7.24K 1.59% 21
2022
Q3 		$7.32M Buy
76,700
+1,450
+2% +$144K 1.56% 20
2022
Q2 		$6.97M Buy
75,250
+10,850
+17% +$1.06M 1.45% 21
2022
Q1 		$6.52M Sell
64,400
-450
-0.7% -$47.3K 0.97% 29
2021
Q4 		$6.69M Sell
64,850
-35
-0.1% -$3.23K 0.91% 28
2021
Q3 		$5.51M Hold
64,885
– – 0.79% 30
2021
Q2 		$5.41M Sell
64,885
-11,000
-14% -$901K 0.79% 36
2021
Q1 		$5.71M Buy
75,885
+750
+1% +$54.6K 0.88% 34
2020
Q4 		$5.13M Sell
75,135
-2,225
-3% -$145K 0.78% 38
2020
Q3 		$4.52M Sell
77,360
-3,450
-4% -$215K 0.79% 40
2020
Q2 		$5.25M Sell
80,810
-75
-0.1% -$4.72K 0.98% 36
2020
Q1 		$4.8M Buy
80,885
+6,935
+9% +$463K 1.24% 30
2019
Q4 		$5.49M Buy
73,950
+18,310
+33% +$1.29M 1% 39
2019
Q3 		$3.51M Buy
+55,640
New +$3.3M 0.73% 51

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bridgecreek Investment Management's CVS Position: Q4 2023 in Review

Bridgecreek Investment Management reduced its CVS Health (CVS) stake by 18% in Q4 2023, selling an estimated $1.01M and leaving 66,225 shares worth $5.23M. The position accounts for 1.01% of the portfolio, ranked #29.

Bridgecreek Investment Management first reported a position in CVS in Q3 2019 and has held it in 18 quarters since. The position peaked at $7.32M in Q3 2022. 2,258 funds tracked by Wall St. Rank hold CVS as of Q4 2023.

  • Bridgecreek Investment Management held 66,225 shares of CVS Health worth $5.23M as of Q4 2023.
  • Bridgecreek Investment Management sold 14,150 CVS Health shares in Q4 2023, an estimated $1.01M.
  • CVS Health made up 1.01% of Bridgecreek Investment Management's portfolio in Q4 2023, its #29 holding.
  • Bridgecreek Investment Management first reported a position in CVS Health in Q3 2019 and has held it in 18 quarters since.
  • Bridgecreek Investment Management's CVS Health position peaked at $7.32M in Q3 2022.
  • 2,258 funds tracked by Wall St. Rank held CVS Health as of Q4 2023.

Based on Bridgecreek Investment Management's 13F filing for Q4 2023, filed 13 Feb 2024.